Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS01 - Symposium by Bayer Healthcare Pharmaceuticals: Precision Medicine: Optimizing The Approach To Lung Cancer Through Testing (Not IASLC CME Accredited)
- 09:45 - 11:15
- 9/07/2019
- Location: Copenhagen (1980)
- Type: Industry Symposia & Workshops
- Track:
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.07 - Activity of Larotrectinib in TRK Fusion Lung Cancer
15:55 - 16:00 | Presenter: Anna F Farago | Author(s): Shivaani Kummar, Victor Moreno, Jyoti D Patel, Ulrik Lassen, Lee Rosen, Nora C. Ku, Michael C. Cox, Shivani Nanda, Barrett H. Childs, David M. Hyman, Alexander Drilon
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.02 - Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases
15:50 - 15:55 | Presenter: Luis Paz-Ares | Author(s): Rafal Dziadziuszko, Alexander Drilon, Tom John, Matthew G Krebs, George Demetri, Alice T. Shaw, Salvatore Siena, Juergen Wolf, Anna F Farago, Brian Simmons, Chenglin Ye, Xinhui Huang, Robert C. Doebele
- Abstract
Loading...
-
+
MS14 - Molecular Subsets and Novel Targeted Approaches to Small Cell and Neuroendocrine Cancers
- 11:30 - 13:00
- 9/10/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Small Cell Lung Cancer/NET
- Moderators:Anna F Farago, Raffaele Califano
-
+
MS14.01 - Molecular Subsets of Neuroendocrine Tumors
11:30 - 11:45 | Presenter: Christine Lee Hann
- Abstract
Loading... -
+
MS14.02 - Subclonal Architecture and Genomic Evolution of SCLC
11:45 - 12:00 | Presenter: Jinghui Wang
- Abstract
Loading... -
+
MS14.03 - Targeting Transcription (Including Lurbinectedin)
12:00 - 12:15 | Presenter: Manuel Cobo
- Abstract
No abstract available for this presentation
-
+
MS14.04 - Targeting DNA Damage and Repair
12:15 - 12:30 | Presenter: Charles M Rudin
- Abstract
Loading... -
+
MS14.05 - DLL3 Targeting Agents
12:30 - 12:45 | Presenter: John T Poirier
- Abstract
Loading... -
+
MS14.06 - Q&A
12:45 - 13:00
- Abstract
No abstract available for this presentation
-
+
OA15 - Targeted Agents and Immunotherapy for Small Cell Lung Cancer
- 14:30 - 16:00
- 9/10/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Raffaele Califano, Charles M Rudin
-
+
OA15.01 - Combination Olaparib and Temozolomide in Relapsed Small Cell Lung Cancer: Updated Results from Phase 1/2 Clinical Trial
14:30 - 14:40 | Presenter: Anna F Farago | Author(s): Beow Yeap, Rebecca S Heist, J Paul Marcoux, Deepa Rangachari, David Barbie, Elizabeth Kennedy, Mari Mino-Kenudson, Alice T. Shaw
- Abstract
Loading...